Alberto Ortíz

203.8k total citations · 11 hit papers
847 papers, 28.9k citations indexed

About

Alberto Ortíz is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Alberto Ortíz has authored 847 papers receiving a total of 28.9k indexed citations (citations by other indexed papers that have themselves been cited), including 367 papers in Nephrology, 190 papers in Molecular Biology and 119 papers in Immunology. Recurrent topics in Alberto Ortíz's work include Chronic Kidney Disease and Diabetes (145 papers), Dialysis and Renal Disease Management (129 papers) and Renal Diseases and Glomerulopathies (90 papers). Alberto Ortíz is often cited by papers focused on Chronic Kidney Disease and Diabetes (145 papers), Dialysis and Renal Disease Management (129 papers) and Renal Diseases and Glomerulopathies (90 papers). Alberto Ortíz collaborates with scholars based in Spain, United States and United Kingdom. Alberto Ortíz's co-authors include Jesús Egido, Ana B. Sanz, María Dolores Sánchez-Niño, Marta Ruiz‐Ortega, Adrián M. Ramos, Beatriz Fernández‐Fernández, Sandra Rayego‐Mateos, Mehmet Kanbay, Raúl R. Rodrigues-Díez and Luis Miguel Blanco‐Colio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Alberto Ortíz

805 papers receiving 28.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting the progression of chronic kidney disease

2020 638 citations Marta Ruiz‐Ortega, Sandra Rayego‐Mateos et al. profile →
Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury

2013 452 citations Andreas Linkermann, Ana B. Sanz et al. Proceedings of the National Academy of Sciences profile →
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI

2016 445 citations Diego Martín‐Sánchez, Susana Carrasco et al. Journal of the American Society of Nephrology profile →
Fabry disease revisited: Management and treatment recommendations for adult patients

2018 401 citations Alberto Ortíz et al. profile →
Chronic kidney disease and the global public health agenda: an international consensus

2024 387 citations Alberto Ortíz, Christoph Wanner et al. profile →
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

2014 310 citations Alberto Ortíz, Mehmet Kanbay et al. profile →
The systemic nature of CKD

2017 300 citations Carmine Zoccali, Alberto Ortíz et al. profile →
Regulated cell death pathways in kidney disease

2023 220 citations Ana B. Sanz, María Dolores Sánchez-Niño et al. profile →
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases

2020 195 citations Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez et al. profile →
Targeting inflammation to treat diabetic kidney disease: the road to 2030

2022 185 citations Sandra Rayego‐Mateos, Raúl R. Rodrigues-Díez et al. Kidney International profile →
The impact of population ageing on the burden of chronic kidney disease

2024 63 citations Alberto Ortíz, Carmine Zoccali et al. profile →

Peers

Countries citing papers authored by Alberto Ortíz

Since Specialization

Citations

This map shows the geographic impact of Alberto Ortíz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Ortíz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Ortíz more than expected).

Fields of papers citing papers by Alberto Ortíz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Ortíz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Ortíz. The network helps show where Alberto Ortíz may publish in the future.

Co-authorship network of co-authors of Alberto Ortíz

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Ortíz. A scholar is included among the top collaborators of Alberto Ortíz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Ortíz. Alberto Ortíz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ultra-processed foods and cardio-kidney-metabolic syndrome: A review of recent evidence 2025 ·European Journal of Internal Medicine ·Mehmet Kanbay, (unknown), (unknown), (unknown), (unknown), Alberto Ortíz	3
2	Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: clinical implications and mechanistic insights in type 2 diabetes 2025 ·Clinical Kidney Journal ·Mehmet Kanbay, (unknown), (unknown), (unknown), (unknown), Alberto Ortíz, (unknown)	0
3	Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality 2025 ·Nefrología (English Edition) ·Patricia de Sequera, (unknown), Borja Quiroga, (unknown), (unknown), (unknown), (unknown), Javier Dı́ez, Alberto Ortíz	1
4	Impact of the Type of Dialysate Acid Concentrate Container on the Environmental Footprint of Hemodialysis Centers 2025 ·American Journal of Kidney Diseases ·(unknown), (unknown), María Dolores Arenas, (unknown), (unknown), James Larkin, (unknown), Alberto Ortíz, Brett Duane	1
5	Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference 2025 ·Kidney International ·Alberto Ortíz, María José Guerra Palmero, Juliana C.N. Chan, (unknown), Holly Kramer, Susanne B. Nicholas, Meda E. Pavkov, Christoph Wanner, Leslie P. Wong, Michael Cheung, Jennifer King, Morgan E. Grams, Michel Jadoul, Katherine R. Tuttle, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
6	Performances of acute kidney injury biomarkers vary according to sex 2024 ·Clinical Kidney Journal ·Stanislas Faguer, (unknown), Ana B. Sanz, Justyna Siwy, (unknown), (unknown), (unknown), Bertrand Marcheix, Audrey Casemayou, Julie Klein, Vincent Minville, Benjamin Breuil, Alberto Ortíz, Joost P. Schanstra	3
7	Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis 2024 ·Nefrología (English Edition) ·Juan F. Navarro‐González, Alberto Ortíz, (unknown), (unknown), Belén Pimentel, (unknown), (unknown), Margarita Capel, (unknown), (unknown), Juan José García Sánchez, Roberto Alcázar Arroyo	0
8	Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology 2024 ·Nefrología (English Edition) ·Aleix Cases, José Jesús Broseta, María Marqués, (unknown), (unknown), Roberto Alcázar Arroyo, Alberto Ortíz	2
9	Sixty years of European Renal Association (ERA) Registry data on kidney disease: visualizing differences in clinical practice 2024 ·Nephrology Dialysis Transplantation ·Vianda S Stel, Kitty J. Jager, Alberto Ortíz	1
10	Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective Factors 2023 ·International Journal of Molecular Sciences ·María Dolores Sánchez-Niño, (unknown), Sol Carriazo, Aránzazu Pintor‐Chocano, Ana B. Sanz, Moin A. Saleem, Alberto Ortíz	3
11	Regulated necrosis role in inflammation and repair in acute kidney injury 2023 ·Frontiers in Immunology ·(unknown), (unknown), Sandra Rayego‐Mateos, Adrián M. Ramos, Marta Ruiz‐Ortega, Alberto Ortíz, Ana B. Sanz	20
12	Novel Treatments Paradigms: Membranous Nephropathy 2023 ·Kidney International Reports ·Jorge Rojas-Rivera, Alberto Ortíz, Fernando C. Fervenza	23
13	Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH) 2023 ·Nephrology Dialysis Transplantation ·Pantelis Sarafidis, Marieta Theodorakopoulou, Alberto Ortíz, Beatriz Fernández‐Fernández, Ionuţ Nistor, Roland E. Schmieder, Mustafa Arıcı, Athanasios Saratzis, Patricia Van der Niepen, Jean‐Michel Halimi, Reinhold Kreutz, Andrzej Januszewicz, Alexandre Persu, Mario Cozzolino	13
14	Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis 2023 ·Nephrology Dialysis Transplantation ·Jorge Rojas-Rivera, Sevcan A. Bakkaloğlu, Davide Bolignano, Ionuţ Nistor, Pantelis Sarafidis, Sokratis Stoumpos, Mario Cozzolino, Alberto Ortíz	6
15	Molecular Mechanisms of Kidney Injury and Repair 2022 ·International Journal of Molecular Sciences ·Sandra Rayego‐Mateos, Laura Márquez‐Expósito, Raquel Rodrigues‐Díez, Ana B. Sanz, Roser Guiteras, (unknown), (unknown), Anna Manonelles, (unknown), Alberto Ortíz, Josep M. Cruzado, Marta Ruiz‐Ortega, Anna Solà	57
16	Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 2021 ·Clinical Kidney Journal ·Anna Pisano, Francesca Mallamaci, Graziella D’Arrigo, Davide Bolignano, Grégoire Wuerzner, Alberto Ortíz, Michel Burnier, Nada Kanaan, Pantelis Sarafidis, Alexandre Persu, Charles J. Ferro, Charalampos Loutradis, Ioannis Boletis, Gérard M. London, Jean‐Michel Halimi, Bénédicte Sautenet, Patrick Rossignol, Liffert Vogt, Carmine Zoccali	18
17	TWEAK and RIPK1 mediate a second wave of cell death during AKI 2018 ·Proceedings of the National Academy of Sciences ·Diego Martín‐Sánchez, Miguel Fontecha‐Barriuso, Susana Carrasco, María Dolores Sánchez-Niño, Anne von Mäßenhausen, Andreas Linkermann, Pablo Cannata‐Ortiz, Marta Ruiz‐Ortega, Jesús Egido, Alberto Ortíz, Ana B. Sanz	118
18	Designing a Method with Physician Participation to Assess and Improve Quality of Healthcare in Otolaryngology 2017 ·The Journal of International Advanced Otology ·(unknown), Catalina Martín Cleary, Carlos Cenjor Español, (unknown), Alberto Ortíz	0
19	Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage 2016 ·Journal of the American Society of Nephrology ·Beatriz Suárez-Álvarez, José Luis Morgado‐Pascual, Sandra Rayego‐Mateos, Ramón María Alvargonzález Rodríguez, Raúl R. Rodrigues-Díez, Pablo Cannata‐Ortiz, Ana B. Sanz, Jesús Egido, Pierre‐Louis Tharaux, Alberto Ortíz, Carlos López‐Larrea, Marta Ruiz‐Ortega	59
20	Renal cell loss through cell suicide 2000 ·Kidney International ·Alberto Ortíz	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact